These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 21205135)
1. The role of genetic markers in hepatitis C virus therapy: a major step for individualized care. McHutchison JG Liver Int; 2011 Jan; 31 Suppl 1():29-35. PubMed ID: 21205135 [TBL] [Abstract][Full Text] [Related]
2. Role of IL28B for chronic hepatitis C treatment toward personalized medicine. Matsuura K; Watanabe T; Tanaka Y J Gastroenterol Hepatol; 2014 Feb; 29(2):241-9. PubMed ID: 24325405 [TBL] [Abstract][Full Text] [Related]
3. Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype. Itokawa N; Atsukawa M; Tsubota A; Kondo C; Hashimoto S; Fukuda T; Matsushita Y; Kidokoro H; Kobayashi T; Narahara Y; Nakatsuka K; Kanazawa H; Iwakiri K; Sakamoto C J Gastroenterol Hepatol; 2013 Mar; 28(3):443-9. PubMed ID: 23173698 [TBL] [Abstract][Full Text] [Related]
4. Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin. Chen Y; Xu HX; Wang LJ; Liu XX; Mahato RI; Zhao YR Aliment Pharmacol Ther; 2012 Jul; 36(2):91-103. PubMed ID: 22591106 [TBL] [Abstract][Full Text] [Related]
5. [IL-28B polymorphism and hepatitis C: impact on viral clearance--prolonged, spontaneous and after treatment with antiviral drugs]. Halfon P; Cacoub P Rev Med Interne; 2011 May; 32(5):271-4. PubMed ID: 21126807 [No Abstract] [Full Text] [Related]
6. Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load. Neukam K; Camacho A; Caruz A; Rallón N; Torres-Cornejo A; Rockstroh JK; Macías J; Rivero A; Benito JM; López-Cortés LF; Nattermann J; Gómez-Mateos J; Soriano V; Pineda JA J Hepatol; 2012 Apr; 56(4):788-94. PubMed ID: 22173157 [TBL] [Abstract][Full Text] [Related]
7. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C. Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692 [TBL] [Abstract][Full Text] [Related]
8. Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C. Ishiguro H; Abe H; Seki N; Sugita T; Aida Y; Itagaki M; Sutoh S; Shimada N; Furihata T; Tsubota A; Aizawa Y World J Gastroenterol; 2015 Apr; 21(13):3904-11. PubMed ID: 25852275 [TBL] [Abstract][Full Text] [Related]
9. An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response. Mangia A; Thompson AJ; Santoro R; Piazzolla V; Tillmann HL; Patel K; Shianna KV; Mottola L; Petruzzellis D; Bacca D; Carretta V; Minerva N; Goldstein DB; McHutchison JG Gastroenterology; 2010 Sep; 139(3):821-7, 827.e1. PubMed ID: 20621700 [TBL] [Abstract][Full Text] [Related]
10. IL28B: A new wager in the skyline of hepatitis C virus infection. Mangia A Dig Liver Dis; 2011 Mar; 43(3):177-9. PubMed ID: 21237729 [No Abstract] [Full Text] [Related]
11. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy. Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177 [TBL] [Abstract][Full Text] [Related]
12. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4. Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823 [TBL] [Abstract][Full Text] [Related]
13. Contribution of ribavirin transporter gene polymorphism to treatment response in peginterferon plus ribavirin therapy for HCV genotype 1b patients. Tsubota A; Shimada N; Yoshizawa K; Furihata T; Agata R; Yumoto Y; Abe H; Ika M; Namiki Y; Chiba K; Fujise K; Tada N; Aizawa Y Liver Int; 2012 May; 32(5):826-36. PubMed ID: 22212648 [TBL] [Abstract][Full Text] [Related]
14. Factors that predict response of patients with hepatitis C virus infection to boceprevir. Poordad F; Bronowicki JP; Gordon SC; Zeuzem S; Jacobson IM; Sulkowski MS; Poynard T; Morgan TR; Molony C; Pedicone LD; Sings HL; Burroughs MH; Sniukiene V; Boparai N; Goteti VS; Brass CA; Albrecht JK; Bacon BR; Gastroenterology; 2012 Sep; 143(3):608-618.e5. PubMed ID: 22626609 [TBL] [Abstract][Full Text] [Related]
15. Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C. Fukuhara T; Taketomi A; Motomura T; Okano S; Ninomiya A; Abe T; Uchiyama H; Soejima Y; Shirabe K; Matsuura Y; Maehara Y Gastroenterology; 2010 Nov; 139(5):1577-85, 1585.e1-3. PubMed ID: 20708617 [TBL] [Abstract][Full Text] [Related]
16. Pegylated interferon-α monotherapy leads to low response rates in HIV-infected patients with acute hepatitis C. Arends JE; van Assen S; Stek CJ; Wensing AM; Fransen JH; Schellens IM; Spijkers SN; Mudrikova T; van Baarle D; Sprenger HG; Hoepelman AI Antivir Ther; 2011; 16(7):979-88. PubMed ID: 22024513 [TBL] [Abstract][Full Text] [Related]
17. Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1. Ogawa E; Furusyo N; Murata M; Ikezaki H; Ihara T; Hayashi T; Toyoda K; Taniai H; Okada K; Kainuma M; Hayashi J J Hepatol; 2012 Sep; 57(3):534-40. PubMed ID: 22613000 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus genotype 4 therapy: progress and challenges. Kamal SM Liver Int; 2011 Jan; 31 Suppl 1():45-52. PubMed ID: 21205137 [TBL] [Abstract][Full Text] [Related]
19. IL28B polymorphisms and chronic hepatitis C. Chevaliez S; Hézode C Gastroenterol Clin Biol; 2010 Nov; 34(11):587-9. PubMed ID: 20889274 [TBL] [Abstract][Full Text] [Related]
20. Interleukin 28B polymorphisms and therapy response in Egyptian hepatitis C genotype-4 patients. Gouda HM; El-Saadany ZA; Foad NB; Salama RM DNA Cell Biol; 2014 Sep; 33(9):642-6. PubMed ID: 24999753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]